Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
MDLinx
Lung Cancer Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA reduces risk of ACS in hospitalized pneumonia patients
41 Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma Full Text Chinese Medical Journal, September 26, 2012 Clinical Article
42 Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas Full Text BMC Cancer, September 26, 2012
43 First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors Full Text Biologics: targets & therapy, September 26, 2012 Clinical Article
44 EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer Full Text Molecular Cancer, September 26, 2012
45 Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literature Full Text BMC Cancer, September 26, 2012
46 Obstructive sleep apnea and multimorbidity Full Text BMC Pulmonary Medicine, September 25, 2012
47 Assessment of measurement properties of peak VO2 in children with pulmonary arterial hypertension Full Text BMC Pulmonary Medicine, September 25, 2012
48 Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study Full Text BMC Cancer, September 25, 2012
49 Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials Full Text PLoS Medicine, September 24, 2012 Clinical Article
50 Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease Full Text International Journal of COPD, September 24, 2012
51 Current asthma control predicts future risk of asthma exacerbation: a 12-month prospective cohort study Full Text Chinese Medical Journal, September 24, 2012
52 Single-agent maintenance therapy in non-small cell lung cancer: a systematic review and meta-analysis Full Text Chinese Medical Journal, September 24, 2012 Clinical Article
53 Prostaglandin E2 as an Inhibitory Modulator of Fibrogenesis in Human Lung Allografts Full Text American Journal of Respiratory and Critical Care Medicine, September 24, 2012 Original Publication Date: September 23, 2011
54 Serum carotenoid concentrations predict lung function evolution in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study Full Text American Journal of Clinical Nutrition, September 23, 2012 Original Publication Date: September 22, 2011
55 Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemo-radiotherapy and an 8-years Update on a Phase I/II Trial Full Text Clinical Cancer Research, September 22, 2012 Original Publication Date: September 21, 2011
56 Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities Full Text Chinese Medical Journal, September 21, 2012
57 Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma Full Text Chinese Medical Journal, September 21, 2012
58 Independent Association Between Obstructive Sleep Apnea and Noncalcified Coronary Plaque Demonstrated by Noninvasive Coronary Computed Tomography Angiography Full Text Clinical Cardiology, September 21, 2012 Clinical Article
59 Quality of life predicts survival in patients with non-small cell lung cancer Full Text BMC Public Health, September 21, 2012
60 Lebrikizumab in the personalized management of asthma Full Text Biologics: targets & therapy, September 20, 2012 Clinical Article
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryAs published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryAs published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summaryIndexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close